in patients treated with a combination of l-dopa and a peripheral decarboxylase inhibitor ( pdi ) , those with dyskinesias have very high plasma o-methyl-dopa levels compared with those who have no dyskinesias .
C0023570
l-dopa
C0013023
dopa